Brief alcohol-focused program tailored for people taking buprenorphine

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Alcohol use can raise overdose risk and undermine retention in buprenorphine-based opioid treatment, yet alcohol interventions have rarely been tailored for this group. This proof-of-concept randomized intervention tests a brief opioid-informed alcohol intervention based on motivational enhancement and cognitive behavioral therapy, adapted to the needs of patients receiving buprenorphine. The study will enroll adults on buprenorphine who meet DSM-5 criteria for alcohol use disorder and who drink at least once per week, then measure feasibility, acceptability, and preliminary alcohol-related outcomes. Findings will guide whether a larger clinical trial is warranted.

Why it matters

Who can join: the full rules

Inclusion Criteria for the RCT:

* Participants must be taking prescribed buprenorphine for at least 2 weeks
* Participants must be 18 years or older.
* Meet DSM-5 criteria for alcohol use disorder (AUD)
* Participants must report alcohol use ≥ 1 day/week on average in the past 28 days
* Participants must be able to read simple English

Exclusion Criteria:

* Currently receiving formal alcohol use treatment.
* Currently experiencing psychosis

Where it's running

• The University of Notre Dame
  Notre Dame, Indiana, United States Recruiting

Study contacts

• Study coordinator: Ryan Carpenter, PhD
• Email: ryancarpenter@nd.edu
• Phone: +1 574-631-5429

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Translating and validating a questionnaire for opioid misuse in Swedish pain patients

  This study is testing a new Swedish questionnaire to see if it can help identify opioid misuse among pain patients who are using opioids for treatment.

  Recruiting Uppsala University · Uppsala, Uppland · NCT06084520

• Impact of MOUD Policy Changes During the Pandemic on Opioid and Alcohol Use Disorders

  This study tests how federal and state policy changes during the COVID-19 pandemic affected access to and use of medications for opioid use disorder among Veterans with opioid or alcohol use disorders.

  Recruiting Boston University · Boston, Massachusetts · NCT07232641

• TMS to help recovery in people with opioid and alcohol use disorders

  This study tests whether short daily TMS sessions can help people with opioid and alcohol use disorders improve recovery outcomes when added to their regular treatment.

  Recruiting Washington State University · Portland, Oregon · NCT07171359

• Lemborexant for insomnia in adults with opioid use disorder on buprenorphine

  This trial will see if taking lemborexant each night for 8 weeks improves sleep, mood, and impulsive behavior in adults with moderate opioid use disorder who are stable on buprenorphine.

  Recruiting Phase 2 Virginia Commonwealth University · Richmond, Virginia · NCT06981195

• Support for people recovering from opioid overdoses in Seattle

  This study tests a new support center for people recovering from opioid overdoses in Seattle to see if it helps them get better care and stay safe compared to those who don’t use the center.

  Recruiting University of Washington · Seattle, Washington · NCT06768814

• Engagement of community health workers to support recovery from substance use disorders

  This study is testing whether support from community health workers can help people with substance use disorders engage better in treatment and improve their recovery experience after visiting the emergency department.

  Recruiting University of California, Los Angeles · Providence, Rhode Island · NCT06320015

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.